BackTHC Biomed Intl Overview
THC Biomed Intl Ltd.

THC Biomed Intl Return on Equity

Latest ROE for THC Biomed Intl: -78.12% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-78.12%

Return on Equity

-78.12%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

THC Biomed Intl (THCBF) FAQ

The latest ROE for THCBF is -78.12%. That is below the sector sector average of 11.3%. Investors often review this figure alongside THC Biomed Intl's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, THCBF currently prints -78.12% for ROE, while the sector average sits near 11.3%. That is roughly 791.6% below the sector mean. Large gaps often invite a closer look at THC Biomed Intl's growth, margins, and balance sheet.

Return on Equity shows how effectively THC Biomed Intl converts resources into returns. At -78.12%, THCBF may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting THCBF's ROE (-78.12%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.